Clinical Trial Update: Evaluate Safety and Efficacy of 25 mg Hydrocortisone Acetate Suppositories in Treatment of Internal Hemorrhoids [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of 25 mg hydrocortisone acetate suppositories for internal hemorrhoids has completed with post results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Internal Hemorrhoids

Drugs mentioned

• Hydrocortisone Acetate Suppositories (hydrocortisone acetate)

Snippet

Sponsor: Nivagen Pharmaceuticals Inc. | Conditions: Internal Hemorrhoids | Phase 2 | Status: COMPLETED | Results posted: 2022-09-13